Product information
From Health Canada
Current status:
Marketed
Current status date:
2024-06-11
Original market date: See footnote 1
2012-10-01
Product name:
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP
Description:
FOR USE WITH APHERESIS DEVICES ONLY. NOT FOR DIRECT I.V. INFUSION.
DIN:
02377411 Electronic product monograph is not available
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
0-Unassigned
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
20:12.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Active ingredient group (AIG) number:See footnote5
0153063001
Active ingredient(s) | Strength |
---|---|
SODIUM CITRATE DIHYDRATE | 4 G / 100 ML |